These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2778469)

  • 1. Should study subjects see their previous responses: data from a randomized control trial.
    Guyatt GH; Townsend M; Keller JL; Singer J
    J Clin Epidemiol; 1989; 42(9):913-20. PubMed ID: 2778469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring functional status in chronic lung disease: conclusions from a randomized control trial.
    Guyatt GH; Townsend M; Keller J; Singer J; Nogradi S
    Respir Med; 1989 Jul; 83(4):293-7. PubMed ID: 2692093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring functional status in chronic lung disease: conclusions from a randomized control trial.
    Guyatt GH; Townsend M; Keller J; Singer J; Nogradi S
    Respir Med; 1991 Sep; 85 Suppl B():17-21; discussion 33-7. PubMed ID: 1759016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.
    Rutten-van Mölken M; Roos B; Van Noord JA
    Thorax; 1999 Nov; 54(11):995-1003. PubMed ID: 10525558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice.
    Mahon JL; Laupacis A; Hodder RV; McKim DA; Paterson NA; Wood TE; Donner A
    Chest; 1999 Jan; 115(1):38-48. PubMed ID: 9925061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should study subjects see their previous responses?
    Guyatt GH; Berman LB; Townsend M; Taylor DW
    J Chronic Dis; 1985; 38(12):1003-7. PubMed ID: 4066888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.
    Guyatt GH; Townsend M; Pugsley SO; Keller JL; Short HD; Taylor DW; Newhouse MT
    Am Rev Respir Dis; 1987 May; 135(5):1069-74. PubMed ID: 3579005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.
    Guyatt GH; Townsend M; Nogradi S; Pugsley SO; Keller JL; Newhouse MT
    Arch Intern Med; 1988 Sep; 148(9):1949-52. PubMed ID: 3046537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
    Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of bronchodilator effect in chronic airflow limitation.
    Jaeschke R; Guyatt GH; Singer J; Keller J; Newhouse MT
    CMAJ; 1991 Jan; 144(1):35-9. PubMed ID: 1984814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
    Nishimura K; Koyama H; Ikeda A; Izumi T
    Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
    Thomas P; Pugsley JA; Stewart JH
    Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction.
    Dullinger D; Kronenberg R; Niewoehner DE
    Chest; 1986 Feb; 89(2):171-3. PubMed ID: 3510820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial to evaluate the effect of informing patients about their pretreatment responses to two respiratory questionnaires.
    Schünemann HJ; Guyatt GH; Griffith L; Stubbing D; Goldstein R
    Chest; 2002 Nov; 122(5):1701-8. PubMed ID: 12426274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
    McKay SE; Howie CA; Thomson AH; Whiting B; Addis GJ
    Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
    Bossert J; Träger E
    Fortschr Med; 1989 Apr; 107(11):255-8. PubMed ID: 2659475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of theophylline in the treatment of dyspnea in COPD.
    Mahler DA
    Chest; 1987 Jul; 92(1 Suppl):2S-6S. PubMed ID: 3297522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.